The in-vitro diagnostics (IVD) landscape in the European Union is evolving with the implementation of the In Vitro Diagnostic Medical Devices Regulation (IVDR) 2017/746. A key aspect of this regulation is the designation of EU IVD Reference Laboratories, particularly for high-risk Class D IVDs. These laboratories play a critical role in ensuring the safety and performance of these devices, ultimately protecting public health.
The Role of EU IVD Reference Laboratories
Under the IVDR, Class D IVDs—those posing the highest risk to public health and patient safety—require stringent conformity assessments, often involving scrutiny by Notified Bodies. EU IVD Reference Laboratories provide expert scientific and analytical support during these assessments, verifying performance claims and evaluating whether devices meet the state-of-the-art standards.
Key Responsibilities of Reference Laboratories:
Impact on Manufacturers of Class D IVDs
The establishment of EU IVD Reference Laboratories brings increased scrutiny and a higher level of documentation and scientific evidence for manufacturers. The involvement of these labs may result in longer conformity assessment timelines but enhances credibility, market acceptance, and reinforces the importance of quality-driven design and validation.
Selection and Designation of Reference Laboratories
EU IVD Reference Laboratories must meet strict criteria, including:
The European Commission oversees the designation process through a public call for applications.
Conclusion EU IVD Reference Laboratories add an essential layer of verification for Class D IVDs, ensuring safety, performance, and reliability. Their involvement reinforces scientific rigor in the conformity assessment process. Manufacturers should prepare for heightened regulatory scrutiny while embracing robust evidence-based validation to ensure smooth market access.
FAQs: EU IVD Reference Laboratories
Q: What are Class D IVDs?
A: High-risk in-vitro diagnostic devices, such as tests for life-threatening infectious diseases, blood donation screening, or blood group determination.
Q: How do EU IVD Reference Laboratories differ from other testing labs?
A: They are officially designated by the European Commission under IVDR, ensuring expertise, accreditation, and unbiased assessments for Class D IVDs.
Q: How does assessment by a Reference Laboratory impact manufacturers?
A: Manufacturers must provide comprehensive scientific evidence and undergo rigorous performance validation.
Q: Where can I find a list of designated EU IVD Reference Laboratories?
A: The European Commission will publish the list once the designation process is finalized.
Q:When did EU IVD Reference Laboratory requirements take effect?
A: The IVDR became fully effective on May 26, 2022, with the designation process ongoing.
Q: What is the role of Notified Bodies in relation to Class D IVDs?
A: They assess whether Class D IVDs meet regulatory requirements and rely on expert input from Reference Laboratories for evaluation.
Q: Can manufacturers choose which Reference Laboratory assesses their device?
A: No, the Notified Body determines laboratory involvement in the conformity assessment process.
If you have any questions, contact us for expert support.
